Anderson Compounding Pharmacy Recalls Interferon Eye Drops for Sterility Concerns
Anderson Compounding Pharmacy is recalling Interferon 1 Million IU/mL Eye Drops due to a lack of sterility assurance. The recall covers all lots distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. Per the rubric, FDA Class II recalls involving significant injury/property-damage reports or structural defects are Severe; lack of sterility assurance in ophthalmic products is a significant risk.
Plain-English summary
Anderson Compounding Pharmacy, Inc. is recalling Interferon 1 Million IU/mL Eye Drops, 1 mL Droptainer. The recall was initiated because the product lacks sterility assurance.
The recall applies to all lots of the product. The distribution pattern is listed as nationwide.
Consumers should stop using the recalled eye drops and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Interferon 1 Million IU/mL Eye Drops, 1 mL Droptainer, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.
- Category
- Drug — Ophthalmic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 68 recalled by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 68 products in this recall →Related recalls
Same manufacturer · Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
See all →- HighAnderson Compounding Pharmacy Recalls Prostaglandin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereProstaglandin Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
- SevereEstrone Oil Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
- SevereAnderson Compounding Pharmacy Recalls HCG Vials Due to Sterility Concerns
FDA (Drugs) · 2019-04-24
- SevereGentamicin Irrigation Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereUS Compounding Recalls Prednisolone Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Cyclo/PE/Trop PF Eye Drops for Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Tropicamide and Phenylephrine Eye Drops for Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Voriconazole Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Phenylephrine PF Sterile Solution Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereUS Compounding Recalls Acetylcysteine 10% Ophthalmic Solution for Sterility Concerns
FDA (Drugs) · 2015-11-25